Jane Street
GBT

Jane Street’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Jane Street’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-213,200
Closed -$14.5M – 10892
2022
Q3 		$14.5M Sell
213,200
-36,600
-15% -$2.02M 0.01% 1346
2022
Q2 		$7.98M Sell
249,800
-5,300
-2% -$155K ﹤0.01% 2010
2022
Q1 		$8.84M Buy
255,100
+192,700
+309% +$5.76M ﹤0.01% 2150
2021
Q4 		$1.83M Sell
62,400
-21,400
-26% -$663K ﹤0.01% 4655
2021
Q3 		$2.13M Buy
83,800
+41,900
+100% +$1.23M ﹤0.01% 4350
2021
Q2 		$1.47M Sell
41,900
-14,100
-25% -$550K ﹤0.01% 4991
2021
Q1 		$2.28M Sell
56,000
-128,400
-70% -$5.9M ﹤0.01% 3759
2020
Q4 		$7.99M Buy
184,400
+167,800
+1,011% +$8.27M ﹤0.01% 1618
2020
Q3 		$915K Sell
16,600
-53,300
-76% -$3.39M ﹤0.01% 4234
2020
Q2 		$4.41M Buy
69,900
+58,700
+524% +$4.03M ﹤0.01% 2006
2020
Q1 		$572K Sell
11,200
-5,200
-32% -$348K ﹤0.01% 3481
2019
Q4 		$1.3M Buy
16,400
+8,700
+113% +$516K ﹤0.01% 2432
2019
Q3 		$374K Sell
7,700
-17,000
-69% -$886K ﹤0.01% 3903
2019
Q2 		$1.3M Buy
+24,700
New +$1.42M ﹤0.01% 2351
2019
Q1 		– Sell
-8,800
Closed -$361K – 5865
2018
Q4 		$361K Buy
+8,800
New +$330K ﹤0.01% 3852
2018
Q3 		– Sell
-28,700
Closed -$1.3M – 5907
2018
Q2 		$1.3M Buy
+28,700
New +$1.31M ﹤0.01% 2426

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Jane Street's GBT Position: Q4 2022 in Review

Jane Street sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 63,922 shares — an estimated $4.35M sold.

Jane Street first reported a position in GBT in Q4 2015 and held it in 22 quarters. The position peaked at $7.34M in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Jane Street reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 63,922 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.35M.
  • Jane Street first reported a position in Global Blood Therapeutics, Inc. in Q4 2015 and held it in 22 quarters.
  • Jane Street's Global Blood Therapeutics, Inc. position peaked at $7.34M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.